These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1216098)

  • 1. Tumor-induced suppression of the in vitro humoral response.
    Lazar K; Niederhuber JE
    Surg Forum; 1975; 26():160-2. PubMed ID: 1216098
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes.
    Donovan G; Dumitrescu R; Popp I; Maltezeanu G
    Neoplasma; 1971; 18(3):241-9. PubMed ID: 5093945
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the spleen in immunological processes].
    Robak T; Płuzańska A
    Postepy Hig Med Dosw; 1980; 33(6):625-41. PubMed ID: 6992130
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response.
    Oren ME; Herberman RB; Canty TG
    J Natl Cancer Inst; 1971 Mar; 46(3):621-8. PubMed ID: 5547316
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of a non-specific cytotoxic factor by splenic cells immunized against allogeneic tumour cells.
    Hottier D; Donner M; Burg C
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):240-3. PubMed ID: 5104840
    [No Abstract]   [Full Text] [Related]  

  • 7. The formalinization of antibody to tumor cells in altering the immune response.
    Ungaro PC; Drake WP; Mardiney MR
    Cancer Res; 1972 Oct; 32(10):2241-7. PubMed ID: 4117036
    [No Abstract]   [Full Text] [Related]  

  • 8. Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice.
    Lewis RE; Cruse JM; Hazelwood J
    Anesth Analg; 1980 Sep; 59(9):666-71. PubMed ID: 7191225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for interaction between T cell populations of tumor-bearing and normal mice in immune suppression.
    Ingenito GG; Calkins CE
    J Immunol; 1981 Sep; 127(3):1236-40. PubMed ID: 6455472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay of lymphoid cells and macrophages in tumour immunity.
    Alexander P; Evans R; Grant CK
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):645-58. PubMed ID: 5050874
    [No Abstract]   [Full Text] [Related]  

  • 11. Destruction of tumor as an "innocent bystander" in an immune response specifically directed against nontumor antigens.
    Prehn RT
    Isr J Med Sci; 1973 Mar; 9(3):375-9. PubMed ID: 4145462
    [No Abstract]   [Full Text] [Related]  

  • 12. [Autoantibodies in intact C57B1 and C3HA line mice and the dynamics of their changes during tumor growth].
    Saraeva ZM; Tereshchenko IP; Kalina MM
    Patol Fiziol Eksp Ter; 1974; (1):62-5. PubMed ID: 4617853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity and tumors].
    Michelazzi L
    Boll Ist Sieroter Milan; 1971; 50(3):185-91. PubMed ID: 4337946
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of spleen cells on cytotoxicity by immune lymph node cells: cell-mediated immune suppression (? enhancement) in vitro.
    Klein WJ
    J Immunol; 1972 Jul; 109(1):51-8. PubMed ID: 5035245
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Defects in cell-mediated and humoral immunity in tumor-bearing mice. Evidence and characterization of suppressor cells ].
    Siegl E; Günther J; Schulze HA; Brock J
    Allerg Immunol (Leipz); 1981; 27(3):153-61. PubMed ID: 6214936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blastomogenic and immunodepressive characteristics of SA7(C8) virus].
    Erkhov VS; Ageenko AI
    Vopr Onkol; 1974; 20(11):40-3. PubMed ID: 4155168
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of reactive metabolites in suppression of humoral immunity by N-nitrosodimethylamine.
    Johnson KW; Munson AE; Kim DH; Holsapple MP
    J Pharmacol Exp Ther; 1987 Mar; 240(3):847-55. PubMed ID: 3559977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.